| Dataset | NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles |
| Category | transcriptomics |
| Type | drug perturbation |
| Description | Dose=1uM, 2-(Pyridin-4-Ylmethylamino)-~{n}-[3-(Trifluoromethyl)phenyl]benzamide, Angiogenesis Inhibitors;VEGFR-2 (FLK-1/KDR) Inhibitors;VEGFR-3 (FLT4) Inhibitors;Inhibitors of Signal Transduction Pathways targeting FLT4, KDR (Novartis, 6398883) |
| External Link | https://pubchem.ncbi.nlm.nih.gov/compound/6398883 |
| Similar Terms | |
| Downloads & Tools |
3 genes differentially expressed following the BE-61-OB65_1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.